Monitoring of intraoperative blood loss: benefit of continuous noninvasive haemoglobin monitoring?

Monitoring of intraoperative blood loss: benefit of continuous noninvasive haemoglobin monitoring? - Intraoperative monitoring of blood loss

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON40097

Enrollment

Registered

2013-03-20

Start date

2013-03-20

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

risico op bloedverlies tijdens en na de operatie blood loss haemoglobin monitoring

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients at the age of 18 years or older, planned for elective surgery at-risk for undetected blood loss -American Society of Anesthesiologists (ASA) classification I, II, III, IV

Exclusion criteria

Exclusion criteria: Patient refusal - Emergency surgery

Design outcomes

Primary

Measure	Time frame
The primary endpoint of this pilot study is the total time a patient*s Hb is below a predetermined transfusion threshold (HbAUC) for administration of red blood cell concentrate.	—

Secondary

Measure	Time frame
Secondary endpoints are the number of perioperative blood transfusions, incidence of overtransfusion, DO2, StO2 and serum concentrations of lactate and high-sensitive troponin T.	—

Countries

Netherlands

Outcome results